HealthCare Global Enterprises BPA estimée Q/Q
Quel est le BPA estimée Q/Q de HealthCare Global Enterprises?
Le BPA estimée Q/Q de HealthCare Global Enterprises Limited est -61.82%
Quelle est la définition de BPA estimée Q/Q?
Le taux de croissance prospectif du BPA trimestriel, d'une année à l'autre , correspond à l'augmentation estimée du BPA d'une entreprise pour le prochain trimestre par rapport à la performance d'un trimestre précédent.
The prospective EPS growth rate is a predicted estimate of the earnings per share growth rate towards the current quarter and expressed as a percentage compared to the respective past quarter. The estimated earnings per share growth rate is an important factor for judging a company's value. Comparing EPS history with stock price history helps determine the most likely future direction of the stock price.
Earnings per share is the monetary value of earnings per outstanding share of common stock for a company. The EPS is usually calculated as profit without preferred dividends divided by weighted average of common stock shares over the past twelve months.
BPA estimée Q/Q des entreprises dans Health Care secteur sur NSE par rapport à HealthCare Global Enterprises
Que fait HealthCare Global Enterprises?
HealthCare Global Enterprises Limited, together with its subsidiaries, provides healthcare services focusing on cancer and fertility. The company offers cancer diagnosis and treatment services through radiation therapy, medical oncology, and surgery; and fertility treatment services, as well as reproductive medicine services, including assisted reproduction, gynecological endoscopy, and fertility preservation under the Milann brand. It also operates four multi-specialty hospitals, including three under the HCG brand in Ahmedabad, Bhavnagar, and Rajkot in the state of Gujarat, as well as one under operations and management contract in Hubli in the state of Karnataka that primarily provide cardiology, neurology, orthopedics, gastroenterology, urology, internal medicine, and pulmonary and critical care. In addition, the company offers medical diagnostic services, including scientific testing and consultancy services in the pharmaceutical and medical sector. As of March 31, 2022, the company operated 22 comprehensive cancer centers, including 1 center in Africa. The company was founded in 1989 and is based in Bengaluru, India.
Entreprises avec bpa estimée q/q similaire à HealthCare Global Enterprises
- Wyndham Destinations Inc a BPA estimée Q/Q de -62.03%
- Madison Square Garden Entertainment a BPA estimée Q/Q de -61.96%
- Garrison Capital a BPA estimée Q/Q de -61.90%
- Integra Resources a BPA estimée Q/Q de -61.90%
- Scynexis Inc a BPA estimée Q/Q de -61.90%
- Xeris Biopharma Inc a BPA estimée Q/Q de -61.90%
- HealthCare Global Enterprises a BPA estimée Q/Q de -61.82%
- Trevi Therapeutics a BPA estimée Q/Q de -61.76%
- Deciphera Pharmaceuticals Inc a BPA estimée Q/Q de -61.59%
- Under Armour Inc a BPA estimée Q/Q de -61.54%
- Medallion a BPA estimée Q/Q de -61.54%
- CytoDyn a BPA estimée Q/Q de -61.54%
- Contango Oil & Gas a BPA estimée Q/Q de -61.54%